
    
      This study will evaluate a three drug regimen in the form of two pills which will be taken
      for 28 days for the prevention of HIV infection. Two drugs are combined in an FDA-approved
      pill called TRUVADA, containing the HIV medications, tenofovir disoproxil fumarate 300mg and
      emtricitabine 200mg, taken as one pill once a day. The third drug is a new formulation,
      raltegravir 400mg pill taken twice a day.
    
  